Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.36 USD | +1.54% | -2.26% | +31.93% |
May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Press Releases